New York Stock Exchange · MRK
Merck & Company, Inc. price
Price history, key statistics, and comparable assets for Merck & Company, Inc..
$128.58
+0.16% ($0.2100)
Historical prices
Price history
Intraday through long-term closing prices. Choose 1 day, 1 week, 1 month, 6 months, year to date, 1 year, 5 years, or all available history.
Point-in-time fields
Key statistics
- Previous close
- $128.37
- Open
- $127.84
- Day range
- $126.68 to $128.75
- 52-week range
- $77.58 to $135.05
- Volume
- 5.07M
- Average volume
- 8.82M
- Market cap
- 317.57B
- P/E ratio (TTM)
- 36.19
Profile
About Merck & Company, Inc.
Merck & Company, Inc. trades on New York Stock Exchange under MRK and is grouped under Health Technology. Figures marked unavailable are not estimated.
Editorial profile
Merck & Company, Inc. overview
Merck & Company, Inc. develops prescription medicines, vaccines, biologic therapies, and animal-health products. Its human-health work spans oncology, vaccines, infectious disease, cardiometabolic care, immunology, and neuroscience, alongside Merck Animal Health. These activities place the company in Health Technology and connect MRK to the specific products, services, customers, and operating assets described in its official materials.
SourcesMerck & Company, Inc.MRK is the common stock quoted on New York Stock Exchange. Merck & Company, Inc.'s investor materials publish quarterly results and an annual report. This profile refers to that local security and operating group, which matters when an issuer has several venues, share classes, depositary receipts, or a name that resembles another company.
SourcesMerck & Company, Inc.Merck & Company, Inc.A genuinely distinguishing feature is that U.S.-listed MRK is Merck & Co., known as MSD outside the United States and Canada, and is not Germany's Merck KGaA. The two companies are separate issuers with different listings, histories, and product portfolios. This is more precise than a broad sector label: it identifies a named platform, product architecture, network, asset base, or corporate structure that separates Merck & Company, Inc. from otherwise similar issuers.
SourcesMerck & Company, Inc.- Security type
- Common Stock
Primary sources
- Merck & Company, Inc. official company profileMerck & Company, Inc. · Retrieved 2026-08-10
- Merck & Company, Inc. investor relationsMerck & Company, Inc. · Retrieved 2026-08-10
- MRK listing informationMerck & Company, Inc. · Retrieved 2026-08-10
Contextual peers
Related assets
MRK questions
Merck & Company, Inc. questions
What business does MRK represent?
MRK represents Merck & Company, Inc., which develops prescription medicines, vaccines, biologic therapies, and animal-health products. Its human-health work spans oncology, vaccines, infectious disease, cardiometabolic care, immunology, and neuroscience, alongside Merck Animal Health.
Which products, services, or operating markets are specifically associated with MRK?
Its human-health work spans oncology, vaccines, infectious disease, cardiometabolic care, immunology, and neuroscience, alongside Merck Animal Health.
What specifically distinguishes the business behind MRK?
For Merck & Company, Inc., the asset-specific distinction is that U.S.-listed MRK is Merck & Co., known as MSD outside the United States and Canada, and is not Germany's Merck KGaA. The two companies are separate issuers with different listings, histories, and product portfolios.
Risk and data disclosure
Read before using this data
Glide provides this market data for informational purposes only. It is not investment advice, a recommendation, or an offer to buy or sell any asset. Prices may be delayed or incomplete. Verify market data and consider your objectives, financial situation, and professional advice before acting.